Viracta Therapeutics gets FDA clearance for early stage carcinoma study
July 21 2021 - 7:15AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From Apr 2024 to May 2024
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From May 2023 to May 2024